Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 3,515.00
-120.00 (-3.30%)
Jul 28, 2026, 3:30 PM KST
Bio Plus Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 94,424 | 90,896 | 66,410 | 65,043 | 56,719 | 37,418 |
Revenue Growth | 18.36% | 36.87% | 2.10% | 14.68% | 51.58% | 53.56% |
Gross Profit Gross Profit Growth | 63,560 | 60,537 | 42,545 | 39,518 | 33,776 | 23,628 |
Operating Income Operating Income Growth | 13,591 | 14,989 | 23,667 | 28,026 | 25,600 | 18,226 |
Net Income Net Income Growth | 13,996 | 15,001 | 14,151 | 25,581 | 21,137 | 10,725 |
Earnings Per Share EPS Growth | 138.98 | 149.00 | 247.00 | 433.36 | 371.18 | 206.94 |
EPS Growth | -58.60% | -39.68% | -43.00% | 16.75% | 79.36% | 9.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 30,745 | 27,182 | 41,673 | 65,002 | 78,951 | 41,028 |
Total Debt Total Debt Growth | 64,048 | 60,061 | 55,658 | 9,260 | 6,769 | 2,182 |
Net Cash (Debt) Net Cash Growth | -33,303 | -32,879 | -13,985 | 55,742 | 72,183 | 38,847 |
Net Cash Growth | - | - | - | -22.78% | 85.81% | 221.31% |
Net Cash Per Share Net Cash Per Share Growth | -474.17 | -480.57 | -244.11 | 919.98 | 1258.45 | 749.58 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,281 | 17,655 | 26,487 | 20,289 | 13,359 | 13,352 |
Capital Expenditures CapEx Growth | -30,749 | -46,582 | -94,999 | -21,092 | -6,530 | -15,312 |
Free Cash Flow Free Cash Flow Growth | -13,468 | -28,927 | -68,513 | -803.37 | 6,829 | -1,959 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 67.31% | 66.60% | 64.07% | 60.76% | 59.55% | 63.15% |
Operating Margin | 14.39% | 16.49% | 35.64% | 43.09% | 45.14% | 48.71% |
Pretax Margin | 18.37% | 19.29% | 26.60% | 50.34% | 48.43% | 37.86% |
Profit Margin | 14.82% | 16.50% | 21.31% | 39.33% | 37.27% | 28.66% |
FCF Margin | -14.26% | -31.82% | -103.17% | -1.23% | 12.04% | -5.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 70.000 | - | - | 70.000 | 70.000 |
Dividend Per Share Growth | 40.00% | - | - | 0% | - |
Dividend Yield | 1.93% | - | - | 1.04% | 1.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.15 | 20.64 | 29.08 | 15.36 | 19.02 | 36.83 |
Forward PE | - | 13.71 | 13.71 | 13.10 | 15.11 | - |
P/FCF Ratio | - | - | - | - | 58.87 | - |
PS Ratio | 2.37 | 3.41 | 6.20 | 6.04 | 7.09 | 10.56 |